1. Introduction {#sec1-molecules-23-02023}
===============

Dietary glucose is supplied by meals, and glucose is stored as glycogen in the liver, kidney, and muscle to enable metabolic energy function \[[@B1-molecules-23-02023]\]. Skeletal muscle is largely responsible for regulating carbohydrate metabolism and achieving energy balance in normal feeding \[[@B2-molecules-23-02023]\]. Accordingly, skeletal muscle function deficit, in particular, age-related and disease-related muscle loss, is associated with many chronic diseases including sarcopenia, diabetes and obesity \[[@B3-molecules-23-02023]\]. Such conditions are still difficult to control because causes of muscle loss are multifactorial and influenced by genetics. Recently, there has been increased interest in various functional foods and medicines for promotion of muscle function and maintenance of muscle balance in condition between protein synthesis and degradation \[[@B4-molecules-23-02023]\].

The root (Dioscoreae Rhizoma, Chinese yam) of *Dioscorea batatas* Decaisne (=*D. oposita* Thunberg) is a perennial trailing plant of the Dioscoreaceae family. The yam, which is one of the most important herbs in traditional medicine, has long been used as a food and medication with various pharmaceutical functions. In herbology, the yam is neutral in nature, sweet in flavor, and mainly manifests its therapeutic actions in the spleen, lung, and kidney meridians \[[@B5-molecules-23-02023],[@B6-molecules-23-02023]\]. Therefore, yams are utilized to cure yin deficiency in metabolic disorders such as diabetes and hyperthyroidism by tonifying and replenishing qi in meridian organs. Yam is also known to have digestive functions in the stomach and intestines, as well as immune-regulatory and antiaging effects. In modern pharmacology, the yam has been studied for its effects on asthma \[[@B7-molecules-23-02023]\], cancer \[[@B8-molecules-23-02023],[@B9-molecules-23-02023],[@B10-molecules-23-02023]\], diabetes \[[@B11-molecules-23-02023],[@B12-molecules-23-02023]\], and liver damage \[[@B13-molecules-23-02023]\], as well as its anti-oxidation, anti-inflammation, and anti-aging effects \[[@B14-molecules-23-02023],[@B15-molecules-23-02023]\]. The yam contains various compounds such as dioscin \[[@B16-molecules-23-02023]\], steroidal saponins \[[@B16-molecules-23-02023],[@B17-molecules-23-02023]\], saponins, gallic acid, vanillic acid \[[@B14-molecules-23-02023]\], allatoin \[[@B12-molecules-23-02023]\], and protodioscin \[[@B18-molecules-23-02023]\]. In recent years, natural dietary compounds have gained increasing attention as adjuvant therapy due to their relative low toxicity and synergistic effects with current chemotherapeutic agents \[[@B19-molecules-23-02023]\].

Allantoin, a diureide of glyoxylic acid, is an active and abundant component of yam \[[@B10-molecules-23-02023],[@B12-molecules-23-02023],[@B20-molecules-23-02023]\]. In vivo studies have shown allantoin to have anti-asthmatic \[[@B20-molecules-23-02023]\], antidiabetic \[[@B12-molecules-23-02023],[@B21-molecules-23-02023]\] and antihypertensive \[[@B22-molecules-23-02023]\] activities, as well as memory-enhancing effects in Alzheimer's disease \[[@B23-molecules-23-02023]\].

We recently conducted a study that provided scientific evidence of the abilities of various herbs to improve obesity, diabetes and sarcopenia based on clinical practice and found that some herbs have good effects that occur via regulation of the differentiation and mitochondria biogenesis in skeletal muscle \[[@B24-molecules-23-02023],[@B25-molecules-23-02023]\]. Therefore, we investigated the effects of yam water extract and its bioactive compound, allantoin, on myoblast differentiation and mitochondrial biogenesis in C2C12 myotubes.

2. Results {#sec2-molecules-23-02023}
==========

2.1. Effects of Yam Extract and Allantoin on Myoblast Differentiation into Myotubes {#sec2dot1-molecules-23-02023}
-----------------------------------------------------------------------------------

To investigate the effects of yam extract and allantoin on myoblast differentiation into myotubes, we determined the expression of Myosin heavy chain (MyHC) mRNA and protein as differentiation markers in C2C12 myotubes using reverse transcriptase (RT)-polymerase chain reaction (RT-PCR) and western blot analysis. Treatment with yam extract (*p* \< 0.05 for 1 mg/mL) and allantoin (*p* \< 0.001 for 0.2 and 0.5 mM) significantly increased the expression of MyHC mRNA ([Figure 1](#molecules-23-02023-f001){ref-type="fig"}A) and protein ([Figure 1](#molecules-23-02023-f001){ref-type="fig"}B) in C2C12 myotubes compared with non-treated cells as a negative control. We also observed MyHC expression in C2C12 myotubes using immunocytochemistry ([Figure 1](#molecules-23-02023-f001){ref-type="fig"}C), which revealed that MyHC-positive myotubes with an elongated and widened cylinder-shape and multiple nuclei were present in greater numbers in yam extract and allantoin-treated cells than non-treated cells. Metformin-treated cells as a positive control group were also shown to exhibit an increase of MyHC expression, but this was lower than for treatment with yam extract or allantoin. These results indicate that yam extract and allantoin can induce myoblast differentiation into myotubes in skeletal muscle cells. In MTT viability assay, we confirmed that the concentrations of yam extract and allantoin for treatment in C2C12 myoblasts did not affect the viability (data not shown).

2.2. Effects of Yam Extract and Allantoin on the Expression of Mitochondria Biogenesis-Regulating Factors in Myotubes {#sec2dot2-molecules-23-02023}
---------------------------------------------------------------------------------------------------------------------

To investigate the effects of yam extract and allantoin on mitochondrial biogenesis in myotubes, we measured the expression of the biogenesis regulating factors, peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), nuclear respiratory factor 1 (NRF-1), transcription factor A, mitochondrial (TFAM) and sirtuin 1 (Sirt-1) mRNA and protein in C2C12 myotubes by RT-PCR and western blot, respectively. Treatment of yam extract (0.5 and 1 mg/mL) and allantoin (0.2 and 0.5 mM) in the myotubes for 24 h increased the expression of PGC1α ([Figure 2](#molecules-23-02023-f002){ref-type="fig"}A,B), NRF-1 ([Figure 2](#molecules-23-02023-f002){ref-type="fig"}C,D), TFAM ([Figure 2](#molecules-23-02023-f002){ref-type="fig"}E,F) and Sirt-1 ([Figure 2](#molecules-23-02023-f002){ref-type="fig"}G,H) mRNA ([Figure 2](#molecules-23-02023-f002){ref-type="fig"}A,C,E,G) and protein ([Figure 2](#molecules-23-02023-f002){ref-type="fig"}B,D,F,H) as compared with non-treated cells. In particular, allantoin in a high concentration (0.5 mM) significantly increased the expression of all regulators of mRNA (*p* \< 0.01 for PGC1α, *p* \< 0.05 for NRF-1, TFAM and Sirt-1) and protein (*p* \< 0.01 for PGC1α, NRF1, and TFAM, *p* \< 0.05 for Sirrt1) compared with non-treated cells. Metformin significantly increased the expression of PGC1α (*p* \< 0.05 for mRNA and protein) and NRF-1 (*p* \< 0.05 for protein) compared with non-treated cells. These results indicate that yam extract and allantoin can enhance mitochondrial biogenesis through upregulation of the expression of the transcription factors.

2.3. Effects of Yam Extract and Allantoin on the AMPK and ACC Pathways in Myotubes {#sec2dot3-molecules-23-02023}
----------------------------------------------------------------------------------

Next, we investigated the effects of yam extract and allantoin on the signaling pathway activated with mitochondrial biogenesis based on an evaluation of the phosphorylation of AMP-activated protein kinase (AMPK) and Acetyl-CoA carboxylase (ACC) in C2C12 myotubes by western blot. Treatment with yam extract (0.5 and 1 mg/mL) and allantoin (0.2 and 0.5 mM) resulted in the increased phosphorylation of AMPK ([Figure 3](#molecules-23-02023-f003){ref-type="fig"}A) and ACC ([Figure 3](#molecules-23-02023-f003){ref-type="fig"}B) in the myotubes. Moreover, treatment with allantoin at a high concentration (0.5 mM) significantly increased the phosphorylation of AMPK (*p* \< 0.001) and ACC (*p* \< 0.01) compared with non-treated cells. Metformin as an AMPK activator also significantly increased the phosphorylation of AMPK (*p* \< 0.001) and ACC (*p* \< 0.05) in myotubes. Metformin significantly increased the phosphorylation of AMPK as AMPK activator (*p* \< 0.001) and ACC (*p* \< 0.05) compared with non-treated cells. These results indicate that yam extract and allantoin can increase the mitochondrial biogenesis in myotubes through activation of the AMPK/ACC signaling pathway.

2.4. Effects of Yam Extract and Allantoin on Glucose Uptake in Myotubes {#sec2dot4-molecules-23-02023}
-----------------------------------------------------------------------

To investigate the effects of yam extract and allantoin on glucose uptake into myotubes, we evaluated the expression of Glucose transporter type 4 (GLUT-4) protein and measured the glucose levels in culture medium and in cells using western blot, glucose consumption assay, and glucose uptake assay, respectively. The results revealed that the expression of GLUT-4 in the myotubes was significantly increased by treatment with yam extract (0.5 and 1 mg/mL) and allantoin (0.2 and 0.5 mM) in a dose-dependent manner. Moreover, allantoin treatment induced a significant increase in GLUT-4 expression (*p* \< 0.05 for 0.2 and 0.5 mM), which was more effective than yam extract treatment ([Figure 4](#molecules-23-02023-f004){ref-type="fig"}A). Additionally, glucose was significantly decreased in culture medium of allantoin-treated myotubes (*p* \< 0.05 for 0.2 and 0.5 mM, [Figure 4](#molecules-23-02023-f004){ref-type="fig"}B), while the cellular levels were significantly increased (*p* \< 0.05 for 0.5 mM, [Figure 4](#molecules-23-02023-f004){ref-type="fig"}C). Metformin treatment also significantly decreased glucose levels in culture medium (*p* \< 0.01) and significantly increased cellular glucose levels (*p* \< 0.001) compared with non-treated cells. Metformin significantly increased GLUT-4 expression (*p* \< 0.05) and glucose uptake (*p* \< 0.05) in myotubes compared with non-treated cells. These results indicate that yam extract and allantoin can stimulate glucose uptake in myotubes by increasing the GLUT-4 expression.

2.5. Effects of Yam Extract and Allantoin on ATP Production in Myotubes {#sec2dot5-molecules-23-02023}
-----------------------------------------------------------------------

To investigate the effects of yam extract and allantoin on energy production in myotubes, we measured the ATP contents in myotubes. As shown in [Figure 4](#molecules-23-02023-f004){ref-type="fig"}D, the treatment of myotubes with yam extract and allantoin led to dose-dependent increases in ATP production, with significantly increased ATP levels being observed in response to allantoin (*p* \< 0.05 for 0.5 mM). Metformin significantly increased ATP production (*p* \< 0.05) in myotubes compared with non-treated cells. These results indicate that yam extract and allantoin can enhance the energy production in myotubes, which might be related to the upregulation of the mitochondrial biogenesis-regulating factors, as shown in [Figure 2](#molecules-23-02023-f002){ref-type="fig"}.

2.6. HPLC Analysis {#sec2dot6-molecules-23-02023}
------------------

To analyze the content of allantoin in yam extract, we conducted HPLC analysis and then compared the retention time of samples with that of authentic standard ([Figure 5](#molecules-23-02023-f005){ref-type="fig"}A). The content of allantoin in yam water extract was subsequently calculated by comparison of peak areas ([Figure 5](#molecules-23-02023-f005){ref-type="fig"}B). The equation of the calibration curves for allantoin was *y* = 16039*x* − 16.79. In addition, the correlation coefficient of the calibration curve was higher than 0.9995, and the concentration of allantoin in the extract was 1.53%. The relative standard deviations of precision and repeatability were 0.67% and 1.85%, respectively.

3. Discussion {#sec3-molecules-23-02023}
=============

Social, health, and technological developments have resulted in increases in the proportion of older people increasing worldwide along with increasing life expectancy \[[@B25-molecules-23-02023]\]. The aging process is responsible for many changes in body composition, particularly a loss of skeletal muscle mass. Muscle mass loss and dysfunction in older people are associated with various types of disease, injury or aging, which significantly increases the cost of health care \[[@B26-molecules-23-02023]\]. Age-related reductions in muscle mass known as sarcopenia induce negative effects on muscle strength and muscle quality, as well as decreased physical function, all of which lead to mobility impairment, disability, fatigue, risk of metabolic disorders, falls, and mortality in older adults \[[@B2-molecules-23-02023]\]. Recent research strategies have focused on factors associated with muscle mass and strength, as well as nutritional interventions; specifically, diets rich in proteins and antioxidant supplements and various exercise-related interventions are thought to increase muscle strength and physical function \[[@B25-molecules-23-02023],[@B27-molecules-23-02023]\]. Although potent pharmaceutical treatments such as hormone therapies, angiotensin converting enzyme inhibitors and ghrelin agonists have been studied, there has been little convincing evidence of their effects or they have induced adverse side effects \[[@B27-molecules-23-02023]\]. Nevertheless, it is necessary to find and implement interventions to prevent and treat sarcopenia in the ageing population.

Dietary supplemental herbs with many beneficial effects have long been considered to enhance health status and physical strength as well as to improve abnormal status among the elderly \[[@B28-molecules-23-02023]\]. Yams are commonly used in medications because of their various pharmaceutical functions, which include the enhancement of the digestive process in the stomach and intestines, immune regulation, and antiaging, antiinflammation and antioxidation effects. In traditional medicine, yams are known as a nourishing herb that alleviates yin deficiency in the spleen, lung, and kidney by providing a supplementary energy (qi), therefore, it is used to treat metabolic syndromes such as obesity, diabetes, and hypothyroidism \[[@B29-molecules-23-02023]\]. In addition, yams have been used to prevent the aging process (e.g., muscle weakness) because they control muscle function by spleen control \[[@B30-molecules-23-02023]\]. However, there is little known about the medicinal effects of yams on muscle function. In the present study, we investigated whether yam extract and its active compound, allantoin, could help enhance the muscle function in myotubes. The results revealed that yam extract and allantoin significantly increased myoblast differentiation into myotubes in C2C12 cells and mitochondrial biogenesis through the upregulation of the mitochondrial transcription factors, PGC1α, TFAM, NRF-1, and Sirt-1 via activation of the AMPK/ACC signaling pathway.

To overcome muscle wasting in sarcopenia, it is necessary to stimulate the myogenesis pathway or inhibit the muscle wasting process. Satellite cells such as C2C12 myoblasts undergo expansion and migration and differentiate into multinucleated fibers, myotubes via myoblasts fusion \[[@B31-molecules-23-02023]\]. Myoblast differentiation is orchestrated by myogenic regulatory factors (MRFs) such as myoblast determination protein (MyoD), MRF4, myogenic factor 5 (Myf5) and myogenin \[[@B31-molecules-23-02023]\]. Mature myotubes also express structural muscle proteins such as tropomyosin and MyHC, which is the motor protein of muscle thick filaments and a specific mature marker protein \[[@B32-molecules-23-02023]\]. In the present study, the treatment of yam extract and allantoin significantly increased the expression of MyHC mRNA and protein in C2C12 myotubes, which was higher than Metformin-treatment, suggesting that yams and allantoin can facilitate myoblast differentiation in muscle cells; however, future investigations of the regulation of MRFs and their signals are still needed to better understand the effects of yams and allantoin on myogenesis. Meanwhile, in MTT assay, allantoin did not decrease the viability up to 1 mM in C2C12 myotubes, but its treatment showed a lower expression of MyHC than treatment with 0.5 mM (data not shown). Therefore, we used concentrations of allantoin at 0.2 and 0.5 mM for this study.

Skeletal muscle, which is a key tissue involved in the control of the energy metabolism, processes up to 75% of insulin-stimulated glucose disposal by the translocation of GLUT4 to the plasma membrane in response to the activation, or resulting in the activation, of the AMP-activated protein kinase (AMPK) pathway \[[@B33-molecules-23-02023]\]. AMPK is a key energy sensor controlling metabolic homeostasis at both the cellular and whole-body levels and is involved in many other cellular processes including cell cycle regulation and endothelial and vascular relaxation \[[@B34-molecules-23-02023]\]. Therefore, it has been considered a subject in recent studies of metabolic syndrome such as obesity, insulin resistance, dyslipidemia, and diabetes mellitus \[[@B34-molecules-23-02023],[@B35-molecules-23-02023]\]. In myoblast differentiation, cellular ATP consumption elevates the cellular AMP/ATP ratio which stimulates ATP generation through AMPK activation \[[@B35-molecules-23-02023],[@B36-molecules-23-02023]\]. AMPK activation mediates the increased expression of GLUT-4 and mitochondrial biogenesis and regulates fatty acid oxidation via the phosphorylation of ACC and the expression of Sirt-1 \[[@B37-molecules-23-02023]\]. Sirt-1 is another downstream regulator of the glucose and lipid metabolism that is known to improve insulin sensitivity and to stimulate mitochondrial biogenesis in skeletal muscle via interaction with AMPK/PGC1α \[[@B38-molecules-23-02023]\]. PGC1α is a major regulator of mitochondrial biogenesis that activates the expression of its downstream transcription factors, NRF-1and TFAM \[[@B39-molecules-23-02023]\]. In the present study, yam extract (0.5 and 1 mg/mL) and allantoin (0.2 and 0.5 mM) increased the expression of PGC1α, Sirt-1, NRF-1, and TFAM in C2C12 myotubes. These results indicate that the increasing levels of glucose uptake and ATP in the myotubes are connected with the upregulation of the mitochondrial biogenesis regulating factors PGC1α, Sirt-1, NRF-1, and TFAM, as well as with activation of the AMPK/ACC pathway. Therefore, yam extract and allantoin could help to elevate energy production by increasing mitochondrial biogenesis in skeletal muscle. Recently, it was reported that metformin increases mitochondrial energy formation in L6 muscle cells \[[@B40-molecules-23-02023]\]. We investigated the effects of yam extract and allantoin on the expression of mitochondrial biogenesis regulating factors, PGC1α, Sirt-1, NRF-1, and TFAM, at one-time treatment point; however, these should be considered at multiple time points to observe any changes in mitochondrial biogenesis.

In *Dioscorea* species, the rhizomes of *D. batatas*, *D. opposite*, and *D. japonica* are commonly used as cultivated edible yams, but many wild varieties have rhizomes with different tastes and are not generally edible. However, it was reported that batatasin IV, raspberry ketone, 2-methoxy-4′-hydroxyacetophenone, (3*R*,5*S*)-3,5-dihydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl) heptane, β-sitosterol, blumenol A, dihydropinosylvin, stilbostemin N, butyl-β-[d]{.smallcaps}-fructofuranoside, allantoin, dioscin, and coreajaponins A(1) and B(2) were found in 50% EtOH extract of *D. japonica* \[[@B41-molecules-23-02023]\], and steroidal saponins such as protodioscin, dioscin, and gracilin were found in CH~3~CN extract of in *D. tokoro* (wild yam) \[[@B18-molecules-23-02023]\], and batatasin I and 6,7-dihydroxy-2,4-dimethoxy phenanthrene were found in MeOH extract of *D. batatas* aerial bulbil \[[@B42-molecules-23-02023]\]. Allantoin was identified in the water extract of flesh and peel of *D. opposite* by HPLC-PAD \[[@B9-molecules-23-02023]\], and of the tuber and bulbil of *D. batatas* by HPLC \[[@B43-molecules-23-02023]\]. In our analysis, allantoin (0.36 mg/mL, 1.53%) was found in the water extract of *D. batatas* rhizome. Meanwhile, we detected additional small peak beside to allantoin in HPLC analysis. Recently, it was reported that the adenosine is detected at similar retention time with allantoin because of similar polar and structure \[[@B44-molecules-23-02023]\], however, it will be necessary to analysis.

We used metformin as a reference drug to compare the efficacy of yam extract and allantoin on mitochondrial biogenesis. Metformin treatment to C2C12 myotubes significantly increased the glucose uptake and ATP levels with upregulation of PGC1α and NRF-1 expression, and phosphorylation of AMPK, but these effects were seen to be lower than in allantoin. Thus, the antidiabetic effects of allantoin have been reported in streptozotocin-induced diabetic rats through modulating lipid profiling and increasing GLP-1 release \[[@B12-molecules-23-02023]\] and glucose uptake with GLUT-4 expression in skeletal muscle \[[@B20-molecules-23-02023],[@B45-molecules-23-02023]\]. Our results also suggest that allantoin has an improvement potential for muscle dysfunction in disease conditions through increasing energy formation in muscle. Under diabetic conditions including insulin resistance, hyperglycemia is a risk factor for age-related loss of muscle mass in sarcopenia, which induces muscle synthesis reduction, chronic inflammation, and mitochondrial dysfunction \[[@B46-molecules-23-02023]\]. Therefore, in our further study, the effects of yam extract and allantoin will be investigated in skeletal muscle dysfunction in type 2 diabetes mouse models which show insulin resistance and impaired mitochondrial function in muscle.

4. Materials and Methods {#sec4-molecules-23-02023}
========================

4.1. Materials {#sec4dot1-molecules-23-02023}
--------------

Allantoin and metformin were purchased from Sigma-Aldrich (St. Louis, MO, USA). DMEM and penicillin/streptomycin solution were acquired from Corning (Corning, NY, USA). Fetal bovine serum (FBS), horse serum (HS) and penicillin/streptomycin (P/S) solution were obtained from Merck Millipore (Temecula, CA, USA). An ATP colorimetric assay kit was procured from BioVision Inc. (Milpitas, CA, USA). Anti-Sirt-1, TFAM, NRF-1, AMPK, phospho-AMPK, total-AMPK, phospho-ACC, and total-ACC antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). Anti-MyHC and GLUT4 antibodies were acquired from Santa Cruz Biotechnology (Dallas, TX, USA). Anti-PGC1α antibody and radioimmunoprecipitation assay (RIPA) buffer were obtained from Thermo Fisher Scientific (Waltham, MA, USA).

4.2. Preparation of Yam Extract {#sec4dot2-molecules-23-02023}
-------------------------------

Dried rhizome of *D. batatas* was purchased from an herbal company (Kwangmyungdang, Ulsan, Korea) and identified by Professor Y.-K. Park, a medical botanist in herbology at College of Korean Medicine, Dongguk University (DUCOM). A voucher specimen was deposited at the herbarium of DUCOM (2017DR). Yams (200 g) were extracted by boiling in2 L of water for 3 h, filtered through Whatman Grade 1 filter paper (Sigma-Aldrich, St Louis, MO, USA), concentrated under a vacuum rotary evaporator (Eyela. Co., Ltd., Tokyo, Japan) at 60 °C, and then lyophilized in a freeze-dryer (IlShinBioBase Co., Yangju, Korea) at −80 °C under 5 mTorr. Yam extract (yield = 11.4%) was stored at 4 °C, dissolved in 1× Phosphate Buffer solution (PBS), and filtered through a syringe filter (0.45 μm, Corning, Wiesbaden, Germany) before being used in in vitro experiments.

4.3. Cell Culture and Drug Treatments {#sec4dot3-molecules-23-02023}
-------------------------------------

C2C12 myoblasts, a mouse skeletal muscle line, were purchased from the American Type Culture Collection (ATCC; Manassas, VA, USA) and grown in DMEM supplemented with 10% (*v*/*v*) FBS and1% P/S solution in a humidified atmosphere of 95% air and 5% CO~2~ at 37 °C. At 85--95% confluence, myoblasts were induced to differentiate in DMEM with 2% HS once every day for an additional 5 days. The C2C12 myotubes were then treated with or without different concentrations of yam extract or allantoin. Metformin (2.5 mM) was used as a positive control drug. Allantoin and metformin were dissolved in 1× PBS (pH 7.4).

4.4. Western Blot {#sec4dot4-molecules-23-02023}
-----------------

After cells were lysed in ice-cold RIPA buffer containing a phosphatase inhibitor cocktail (Thermo Fisher Scientific), lysates were centrifuged at 12,000× *g* for 20 min at 4 °C. Protein concentrations of the lysates were then quantified using the protein assay solution (BioRad, Hercules, CA, USA). Next, 50 μg of protein was separated by SDS-polyacrylamide gel electrophoresis (PAGE) and transferred onto nitrocellulose membrane. The membrane was then blocked with 5% skim milk for 1 h at room temperature, after which it was immunoblotted with primary antibodies against MyHC, PGC1α, NRF-1, TFAM, Sirt-1, AMPK (total or phosphor-forms), and ACC (total or phosphor forms), as well as β-actin as an internal control overnight at 4 °C. Following immunoblotting, the membranes were washed three times with 1× tris-buffered saline (pH 7.4) containing 0.1% tween-20 (TBST) buffer, then reacted with horseradish peroxidase (HRP)-labeled anti-mouse or anti-rabbit IgG. All immunoblots were subsequently washed with 1× TBST three times, then developed using ECL^TM^ Western blotting detection reagent (GE Healthcare, Pittsburgh, PA, USA). Finally, bands were detected using a ChemiDoc MP Imaging System (BioRad, Hercules, CA, USA) and quantified by densitometry using the Image J programing software (1.51p 22 for Windows, NIH, Bethesda, MD, USA).

4.5. Reverse Transcriptase (RT)-Polymerase Chain Reaction (RT-PCR) {#sec4dot5-molecules-23-02023}
------------------------------------------------------------------

Total RNA was isolated from cells by TRIzol reagent (GibcoBRL Life Technologies Inc., Grand Island, NY, USA) according to the manufacturer's instructions. The RNA concentration was then quantified using a Nano Drop ND-1000 spectrophotometer (NanoDrop Technologies, Inc., Wilmington, DE, USA). Next, cDNA was generated from 1 µg of total RNA using a Reverse Transcription System kit (Promega, Fitchburg, WI, USA), after which RT-PCR was conducted using a Blend Taq PCR kit (Toyobo, Osaka, Japan) and primers specific to the target genes ([Table 1](#molecules-23-02023-t001){ref-type="table"}). For PCR, the samples were subjected to pre-denaturation at 94 °C for 2 min, followed by 30 cycles of denaturation for 30 s at 94 °C, annealing for 30 s at 56--60 °C, and extension for 1 min at 72 °C. Finally, the bands were detected with the BioRad ChemiDoc MP imaging system and quantified by densitometry using the Image J programming software.

4.6. Immunocytochemistry {#sec4dot6-molecules-23-02023}
------------------------

Differentiated myotubes were seeded on Thermanox plastic cover slips (Nunc^TM^, Thermo Fisher Scientific) and differentiated using a common culture method for 5 days. Samples on cover slips were then fixed with 4% paraformaldehyde for 10 min, after which they were permeabilized with 0.1% Triton X-100 (Sigma-Aldrich) for 20 min. After washing with 1× PBS, cover slips were blocked with 5% bovine serum albumin (BSA) for 30 min at room temperature, then incubated with anti-MyHC antibody overnight at 4 °C. Cover slips were subsequently labelled with AlexaFluor 488-conjugated goat anti-rabbit antibody for 1 h at room temperature, then counterstained with DAPI for 5 min. Finally, the expression of MyHC was observed using a fluorescence microscope (Leica DM2500, Leica microsystems, Wetzlar, Germany).

4.7. Glucose Assay {#sec4dot7-molecules-23-02023}
------------------

Glucose consumption was determined in culture media using a glucose assay kit (Sigma-Aldrich, St. Louis, MO, USA). Briefly, cell culture supernatants were harvested and diluted with deionized water, after which 50 μL of the diluted sample was mixed with an equal volume of assay buffer including *o*-dianisidine in a 96-well plate. The mixture was then incubated at 37 °C for 30 min, at which time the reaction was stopped by adding 50 μL of H~2~SO~4~ and the absorbance (O.D.) at 540 nm was measured in a microtiter reader (UVM340, Asys Hitech Gmbh, Eugendorf, Austria). The glucose consumption in each sample was calculated using a calculation formula from a standard curve.

Next, the cellular levels of glucose were measured in C2C12 myotubes using a glucose uptake cell-based assay kit (Cayman Chemical Co., Ann Arbor, MI, USA). Briefly, C2C12 myotubes were treated with or without yam extract and allantoin at different concentrations in glucose-free medium containing 100 µg/mL of 2-\[*N*-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino\]-2-deoxy-[d]{.smallcaps}-glucose (NBDG) for 4 h. After harvesting the cells, cell-based assay buffer (200 µL) was added to each well. The amount of 2-NBDG taken up by the myotubes was then measured with fluorescent filters that detected fluorescein (excitation/emission = 485/650) using a Glomax multi detection system (Promega Biosystems, Sunnyvale, CA, USA).

4.8. ATP Assay {#sec4dot8-molecules-23-02023}
--------------

Total ATP contents were determined using an ATP colorimetric assay kit (BioVision) according to the manufacturer's instructions. Briefly, C2C12 myotubes were harvested and homogenized in 100 μL ATP assay buffer, after which 50 μL of deproteinized cell lysate was mixed with 50 μL of reaction mix containing ATP probe, ATP converter, and developer in a 96-well plate. The mixture was subsequently incubated at room temperature for 30 min, at which time the absorbance (O.D.) at 570 nm was measured using a microtiter reader. Finally, the concentration of ATP (μM) in each sample was calculated using a calculation formula generated from a standard curve.

4.9. HPLC Analysis {#sec4dot9-molecules-23-02023}
------------------

To identify allantoin in yam extract, HPLC was conducted using an Agilent 1260 infinity II quaternary system equipped with a G7129A vial sampler and a WR G7115 Adiode array detector (Agilent, Waldbronn, Germany) and a ZORBAXNH2 column (4.6 × 150 mm, 5-micron). Chromatographic separation was performed using a gradient solvent system consisting of acetonitrile (HPLC grade, Merck, Darmstadt, Germany) (B) and water (HPLC grade, Merck) (A). The gradient program was as follows: 0 min, 25% B; 5 min, 17% B; 10 min, 17% B. The injection volume was 10 μL and the column eluent was monitored at UV 200 nm while chromatography was performed at 30 °C with a flowrate of 1.0 mL/min. The HPLC pattern of allantoin in yam water extract has been reported in the literature \[[@B9-molecules-23-02023],[@B26-molecules-23-02023]\].

4.10. Statistical Analysis {#sec4dot10-molecules-23-02023}
--------------------------

The data are presented as means ± standard errors of means (SEMs) of three independent experiments. Differences between groups were identified by the Student's *t*-test using the GraphPad Prism program (ver. 5.0, GraphPad Software, La Jalla, CA, USA) and *p*-values \< 0.05 were considered statistically significant.

5. Conclusions {#sec5-molecules-23-02023}
==============

Yam water extract and its active compound, allantoin, significantly improved C2C12 myoblast differentiation into myotubes by increasing the MyHC expression. In addition, these compounds significantly increased the glucose uptake and ATP production in myotubes through the upregulation of the mitochondrial biogenesis-regulating factors PGC1α, NRF-1, TFAM, and Sirt-1 and activation of the AMPK/ACC signaling pathway. In particular, the effects of allantoin on biogenesis were shown to be more pronounced than metformin. Our results suggest that yam and allantoin can help prevent energy loss in muscle dysfunction and are applicable for use as natural sources for food materials and medication for the prevention of sarcopenia and treatment.
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ACC

Acetyl-CoA carboxylase

AMPK

AMP-activated protein kinase

BSA

Bovine serum albumin

DMEM

Dulbecco's modified Eagle's medium

FBS

Fetal bovine serum

HRP

Horseradish peroxidase

HS

Horse serum

MRFs

Myogenic regulatory factors

Myf5

Myogenic factor 5

MyoD

Myoblast determination protein

MyHC

Myosin heavy chain

NRF-1

Nuclear respiratory factor-1

RT-PCR

Reverse transcriptase-polymerase chain reaction

PAGE

Polyacrylamide gel electrophoresis

PBS

Phosphate buffered saline

PGC1α

Peroxisome proliferator-activated receptor gamma coactivator

RIPA

Radioimmunoprecipitation assay

Sirt-1

Sirtuin 1

TBST

Tris-buffered saline containing 0.1% tween-20

TFAM

Transcription factor A, mitochondrial

HPLC

High Performance Liquid Chromatography

![Effects of yam extract and allantoin on the expression of MyHC protein and mRNA in C2C12 myotubes. C2C12 myoblasts were differentiated with DMEM containing 2% HS for 5 days, then treated with or without yam extract (0.5 and 1.0 mg/mL) or allantoin (0.2 and 0.5 mM) for 24 h. Metformin (2.5 mM) was used as a positive control. The expression of MyHC mRNA (**A**) and protein (**B**) was determined by RT-PCR and western blot, respectively. GAPDH and β-actin were used as internal controls. All data were presented as the means ± SEM of three independent experiments. Y, yam extract; A, allantoin; and M, metformin. \* *p* \< 0.05 and \*\*\* *p* \< 0.001 vs. non-treated cells; (**C**) the myotubes were stained with anti-MyHC antibody and DAPI, then observed by fluorescence microscopy (original magnification = 200×). Green, MyHC-positive cells; and blue, DAPI-positive nuclei.](molecules-23-02023-g001){#molecules-23-02023-f001}

![Effects of yam extract and allantoin on the expression of mitochondrial biogenesis-regulating factors in C2C12 myotubes. Differentiated myotubes were treated with or without yam extract (0.5 and 1.0 mg/mL) or allantoin (0.2 and 0.5 mM) for 24 h, after which the expression of PGC1α (**A**,**B**), NRF-1 (**C**,**D**), TFAM (**E**,**F**) and Sirt-1 (**G**,**H**) mRNA (**A**,**C**,**E**,**G**) and protein (**B**,**D**,**F**,**H**) was analyzed by RT-PCR (**A**,**C**,**E**) and western blot (**B**,**D**,**F**), respectively. Metformin (2.5 mM) was used as a positive control. GAPDH and β-actin were used as internal controls. Each band was presented as a representative figure and the histogram was calculated from the band density value of each experiment. All data were presented as the means ± SEM of three independent experiments. Y, yam extract; A, allantoin; and M, metformin. \* *p* \< 0.05, \*\* *p* \< 0.01 and \*\*\* *p* \< 0.001 vs. non-treated negative control.](molecules-23-02023-g002){#molecules-23-02023-f002}

![Effects of yam extract and allantoin on the phosphorylation of AMPK and ACC protein inC2C12 myotubes. Differentiated C2C12 myotubes were treated with or without yam extract (0.5 and 1.0 mg/mL) or allantoin (0.2 and 0.5 mM) for 24 h and the phosphorylation of AMPK (**A**) and ACC (**B**) protein was investigated by western blot. Metformin (2.5 mM) was used as a positive control. Each band was presented as a representative figure and a histogram was calculated from the band density value of each experiment. β-actin were used as an internal control. All data were presented as the means ± SEM of three independent experiments. Y, yam extract; A, allantoin; and M, metformin. \* *p* \< 0.05, \*\* *p* \< 0.01 and \*\*\* *p* \< 0.001 vs. non-treated negative control.](molecules-23-02023-g003){#molecules-23-02023-f003}

![Effects of yam extract and allantoin on the expression of GLUT-4 and the levels of glucose in C2C12 myotubes. Differentiated myotubes were treated with or without yam extract (0.5 and 1 mg/mL) or allantoin (0.2 and 0.5 mM) for 24 h. (**A**) The expression of GLUT-4 protein was determined by western blot. Metformin (2.5 mM) was used as a positive control and β-actin was used as an internal control. Each band was presented as a representative figure and a histogram was calculated from the band density value of each experiment. The levels of glucose in culture medium (**B**) and in the cells (**C**) were measured by a glucose consumption assay and glucose uptake assay, respectively. The contents of ATP in the myotubes were measured using an ATP assay kit (**D**). All data were presented as the means ± SEM of three independent experiments. Y, yam extract; A, allantoin; and M, metformin. \* *p* \< 0.05 and \*\* *p* \< 0.01 vs. non-treated negative control.](molecules-23-02023-g004){#molecules-23-02023-f004}

![HPLC analysis of allantoin in the yam extract: (**A**) allantoin as a standard compound, and (**B**) allantoin in the water extract. a, allantoin (retention time: 3.253 min).](molecules-23-02023-g005){#molecules-23-02023-f005}
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Primer sequences of the target genes for PCR.

  Primers                    Accession No.                     Sequence (5′→3′)
  --------- ---------------- --------------------------------- -------------------------------
  MyHC      Forward          NM 001039545.2                    TGA ACT GGA GGG TGA GGT AG
  Reverse   NM 001039545.2   TTC GGT CTT CTT CTG TCT GG        
  PGC1α     Forward          XM 006503779.3                    CAC CAA ACC CAC AGA AAA CAG
  Reverse   XM 006503779.3   GGG TCA GAG GAA GAG ATA AAG TTG   
  NRF-1     Forward          XM 017321445.1                    ACC CTC AGT CTC ACG ACT AT
  Reverse   XM 017321445.1   GAA CAC TCC TCA GAC CCT TAA C     
  TFAM      Forward          XM 017313918.1                    CAC CCA GAT GCA AAA CTT TCA G
  Reverse   XM 017313918.1   CTG CTC TTT ATA CTT GCT CAC AG    
  Sirt-1    Forward          NM 001159589.2                    GAT CCT TCA GTG TCA TGG TT
  Reverse   NM 001159589.2   GAA GAC AAT CTC TGG CTT CA        
  Gapdh     Forward          XM_017321385.1                    CAG CCT CGT CCC GTA GAC A
  Reverse   XM_017321385.1   CGC TCC TGG AAG ATG GTG AT        
